National Health Investors, Inc. (NHI) to Release Earnings on Monday
National Health Investors, Inc. (NYSE:NHI) will be posting its quarterly earnings results before the market opens on Monday, November 6th. Analysts expect National Health Investors to post earnings of $0.92 per share for the quarter. National Health Investors has set its FY17 guidance at $5.22-5.26 EPS.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The firm had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same quarter in the previous year, the business earned $1.22 earnings per share. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. On average, analysts expect National Health Investors to post $5.26 EPS for the current fiscal year and $5.45 EPS for the next fiscal year.
Shares of National Health Investors, Inc. (NHI) traded down 0.24% on Monday, hitting $76.07. The stock had a trading volume of 6,966 shares. National Health Investors, Inc. has a 52-week low of $66.31 and a 52-week high of $81.21. The firm has a market cap of $3.12 billion, a PE ratio of 19.54 and a beta of 0.56. The firm’s 50-day moving average price is $77.98 and its 200 day moving average price is $77.13.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be given a $0.95 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.98%. National Health Investors’s dividend payout ratio (DPR) is presently 97.69%.
A number of brokerages recently issued reports on NHI. BidaskClub cut National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a research report on Tuesday, September 5th. BMO Capital Markets reissued a “hold” rating and issued a $80.00 target price on shares of National Health Investors in a research report on Wednesday, October 18th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $82.00 target price on shares of National Health Investors in a research report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $80.14.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by company insiders.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.